Recent News

• 08.05.2025 - Day One Biopharmaceuticals Q2 2025 Earnings Conference Call
• 08.05.2025 - Day One Reports Second Quarter 2025 Financial Results and Corporate Progress
• 07.31.2025 - Meeting the Moment: Transforming Oncology Care Through Innovation, Urgency,  and Empathy
• 07.25.2025 - Jeremy Bender on Biotech2050
• 07.22.2025 - Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025
• 06.10.2025 - 46th Annual Goldman Sachs Global Healthcare Conference
• 06.10.2025 - Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development

Recent Filings

• 08.05.2025 - EX-99.1 EX-99.1
• 08.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.05.2025 - 8-K Current report
• 07.17.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 07.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.18.2025 - 3 Initial statement of beneficial ownership of securities
• 06.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.04.2025 - 4 Statement of changes in beneficial ownership of securities